Table 3.
Antiarrhythmic therapy and follow-up.
| No | Types | Antiarrhythmic therapy | Antiarrhythmic time after discharge | Recurrence (time) | Death time | Causes of death | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ATP | Propafenone | Metoprolol | Sotalol | Propranolol | Cedilanid | Digoxin | Benazepril | Lidocaine | Verapamil | Cardioversion | Defibrillation | ||||||
| 1* | JR | √ | √ | √ | 6 mo | 1 | — | — | |||||||||
| 2* | PAC | √ | 0 | 0 | — | — | |||||||||||
| 3* | PAC | √ | 10 d | 0 | — | — | |||||||||||
| 4* | PVC | √ | 10 d | 0 | — | — | |||||||||||
| 5 | SVT | √ | √ | 10 d | 0 | — | — | ||||||||||
| 6 | SVT | √ | √ | 10 d | 0 | — | — | ||||||||||
| 7 | SVT | √ | √ | √ | √ | 36 mo | 5 | — | — | ||||||||
| 8 | SVT | √ | √ | √ | √ | √ | 18 mo | 0 | — | — | |||||||
| 9 | SVT | √ | √ | 6 mo | 2 | — | — | ||||||||||
| 10 | SVT | √ | √ | 0 | 1 | — | — | ||||||||||
| 11 | SVT | √ | √ | √ | 12 mo | 10 | — | — | |||||||||
| 12 | SVT | √ | √ | √ | √ | 10 d | 0 | — | — | ||||||||
| 13 | SVT | √ | 0 | 1 | — | — | |||||||||||
| 14 | SVT | √ | 1 mo | 0 | — | — | |||||||||||
| 15 | SVT | √ | 18 mo | 2 | — | — | |||||||||||
| 16 | SVT | √ | √ | √ | 0 | 1 | — | — | |||||||||
| 17 | SVT | √ | √ | √ | √ | 24 mo | 5 | — | — | ||||||||
| 18 | SVT | √ | √ | √ | 18 mo | 1 | — | — | |||||||||
| 19 | SVT | √ | 8 mo | 3 | — | — | |||||||||||
| 20 | SVT | √ | √ | 10 d | 0 | — | — | ||||||||||
| 21 | SVT | √ | 22 mo | 4 | — | — | |||||||||||
| 22 | SVT | √ | √ | √ | √ | 17 mo | 4 | — | — | ||||||||
| 23 | SVT | √ | 0 | 0 | — | — | |||||||||||
| 24 | SVT | √ | √ | 10 d | 0 | — | — | ||||||||||
| 25 | SVT | √ | 10 d | 0 | — | — | |||||||||||
| 26 | SVT | √ | 6 mo | 0 | — | — | |||||||||||
| 27 | SVT | √ | 0 | 0 | — | — | |||||||||||
| 28 | SVT | √ | √ | √ | 24 mo | 2 | — | — | |||||||||
| 29 | SVT | √ | √ | 0 | 0 | — | — | ||||||||||
| 30 | SVT | √ | √ | √ | √ | 18 mo | 15 | — | — | ||||||||
| 31 | SVT | √ | √ | 0 | 1 | — | — | ||||||||||
| 32 | SVT | √ | 1 mo | 0 | — | — | |||||||||||
| 33 | SVT | √ | √ | √ | 3 mo | 1 | — | — | |||||||||
| 34 | SVT | √ | √ | 0 | 0 | 1.67 mo | Septic shock | ||||||||||
| 35 | SVT | √ | √ | √ | 10 d | 1 | 2.50 mo | Arrhythmia | |||||||||
| 36 | SVT | √ | 0 | 0 | 15 d | TGA | |||||||||||
| 37 | SVT | √ | √ | √ | 2 mo | 1 | 2 mo | Coarctation of the aorta | |||||||||
| 38 | AFL | √ | 1 mo | 20 | 6 mo | Respiratory failure | |||||||||||
| 39 | AFL | √ | √ | √ | 2 mo | 1 | — | — | |||||||||
| 40 | AFL | √ | √ | √ | 2 mo | 0 | — | — | |||||||||
| 41 | AFL | √ | √ | 0 | 0 | — | — | ||||||||||
| 42 | AFL | √ | √ | 0 | 1 | — | — | ||||||||||
| 43 | AFL | √ | 1 mo | 0 | — | — | |||||||||||
| 44 | AFL | √ | 12 mo | 0 | — | — | |||||||||||
| 45 | VF | √ | √ | 10 d | 0 | — | — | ||||||||||
| 46 | VT | √ | 10 d | 0 | — | — | |||||||||||
| 47 | VT | √ | 0 | 0 | — | — | |||||||||||
| 48 | VT | √ | √ | 1 mo | 1 | — | — | ||||||||||
JR, junctional arrhythmia; PAC, premature atrial contraction; PVC, premature ventricular contraction; SVT, Supraventricular tachycardia; AFL, atrial flutter; VT, ventricular tachycardia; VF, ventricular fibrillation; AV, atrioventricular; ATP, adenosine triphosphate; TGA, complete transposition of the great artery.
*
Benign NA group.